You are here: Industry Insights > antibiotic

News List

Shionogi launches novel antibiotic Fetcroja in the UK pharmatimes
September 16, 2020
Japanese pharma company Shionogi has announced that its new antibiotic Fetcroja (cefiderocol) is now available for use in the UK, the first country to launch the drug following its European Commission (EC) approval earlier this year.
GARDP and Bugworks sign MoU to develop antibiotics for serious bacterial infections expresspharma
August 31, 2020
The collaboration includes working together for the preparation of regulatory strategies, in particular for clinical development programmes and post-approval studies.
MicuRx Commits Funding for Development of MRX-8 americanpharmaceuticalreview
August 18, 2020
MicuRx Pharmaceuticals announced the global partnership Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) has committed up to US$7.78 million of nondilutive financing for a Phase 1 clinical trial and related R&D activities ...
Destiny Pharma’s novel antibiotic asset clears safety review pharmatimes
August 12, 2020
Brighton, UK-based Destiny Pharma has announced a positive interim safety review of its ongoing Phase IIb study of its lead antibiotic asset XF-73.
UK-India experts’ drive to stop antibiotic waste creating more ‘superbugs’ expresspharma
August 10, 2020
The project is part of £8 million package of UK-India government-backed research which also comprises programmes to tackle AMR.
Lupin recalls 35,928 bottles of Cefdinir, generic antibiotic drug in the US expresspharma
August 03, 2020
Lupin is recalling 35,928 bottles of a generic antibiotic drug in the US market following unfavourable result in retention samples, informed the US FDA in a report.
How the AMR Action Fund intends to support antibiotic-focused biotechs expresspharma
July 24, 2020
While focus is on the global deaths from COVID-19 crossing the six lakh mark, we have lost seven lakh people to antimicrobial resistance (AMR) each year, which is why more than 20 biopharmaceutical companies recently announced the launch of the AMR ...
US FDA declines approval again for Nabriva’s antibiotic for UTI expresspharma
June 22, 2020
The company said it plans to request a meeting with the FDA to discuss the next steps.
WHO stresses need for new treatments to reduce antimicrobial resistance europeanpharmaceuticalreview
June 15, 2020
Following a record level of data collated by WHO, the organisation has emphasised that new antibiotics need to be developed to tackle the rise of global antimicrobial resistance.
Forge, Roche Enter Antibiotic Alliance contractpharma
March 26, 2020
To develop novel antibiotic to treat serious lung infections attributed to antibiotic-resistant Gram-negative bacteria.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page